Shandong Xinhua Pharmaceutical Company Limited (SHNXY)

18.19 0.00 (0.00%) At close: 03:30PM EDT

Shandong Xinhua Pharmaceutical Company Limited

Chemical Industry Area
Zibo Hi-tech Industry Development Zone
Zibo 255005
China
86 53 3216 6666
https://www.xhzy.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 7,104

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Tongqing He	Chairman & Deputy GM	226.48k	N/A	1970
Mr. Wenhui Xu	GM & Executive Director	213.65k	N/A	1977
Mr. Ning Hou	CFO, Financial Controller & Executive Director	179.84k	N/A	1974
Mr. Zhonghui Zheng	Deputy General Manager	N/A	N/A	1972
Mr. Changsheng Wei	Deputy GM & Manager of Administrative Personnel Department	N/A	N/A	1971
Mr. Xuesong Liu	Deputy General Manager	N/A	N/A	1985
Mr. Changqiu Cao	Company Secretary	N/A	N/A	1970
Mr. Zuxing Kou	Deputy General Manager	N/A	N/A	1982
Ms. Haifeng Guo	Head of Accounting Department	N/A	N/A	N/A
Mr. Xiaohong He	Chief of Finance Department	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally. The company offers antipyretic and analgesic drugs; cardiovascular and cerebrovascular drugs; anti-infective drugs and central nervous drugs; and other drugs. It engages in the development of real estate business. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.

Corporate Governance

Shandong Xinhua Pharmaceutical Company Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.